Paint Cans Market Important Changes in Industry Dynamics during 2021-2031

The global paint cans market was valued at 4.7 Bn by 2021, and is projected to register modest growth during the next ten years. As indicated by a new report presented by Future Market Insights (FMI), sustained demand for paint cans within construction and wall décor segments will continue to push paint can sales at a steady pace over the years to come.

High Recyclability Quotient Sustains Metal Paint Can Sales

Paint cans are widely used to store paint. In fact, they are the most dominant form of packaging solution used for paint. Metal paint cans are generally preferred due to their high recyclability. However, there are certain factors associated with convenience, which could hamper the growth in the adoption of metal paint cans. These include problems such as rusting of paint cans, which can damage the paint inside.

Moreover, most metal paint cans are tightly sealed, and spill paint when opened with force. The paint spilling out of paint cans can stick to the surface. On the other hand, plastic paint cans can be easily decorated and have better compatibility with printing, which is taken advantage of, by paint can manufacturers.

Download sample copy @ https://www.futuremarketinsights.com/reports/sample/rep-gb-6677

Paint Cans Continue to Witness Steady Traction, Construction & Wall Décor Key Revenue Generation Areas

Since a significant chunk of the demand for paint cans is generated by the construction sector, there is a demand for packaging solutions with high capacity. This is fulfilled by plastic containers and pails which have a capacity of well over 5000 ml. Several 5 gal containers of latex-paint sold in the market come in plastic containers. Plastic pails and bulk containers lead to reduced weight of the packaging, ensuring user convenience. The high demand for rigid plastic pails in the construction sector could, to some extent, hamper the growth of the global paint cans market.

The building and construction sector is expected to witness solid growth in the coming years, especially in high growth countries such as Brazil, India, and China. Also, the increasing number of new construction projects, as well as a number of households, is expected to boost the growth of the wall paint market, which, in turn, is anticipated to represent lucrative opportunities for the global paint cans market during the forecast period.

Paint Consumption Sees an Upsurge in Developing Asian Economies, Pushing Sales of Paint Cans

The South & East Asia paint cans market is expected to represent significant revenue growth opportunity during the forecast period. The high rate of urbanization, rise in the number of single person households, and robust growth of the building & construction industry is expected to generate significant demand for paint cans during the forecast period. Therefore, the manufacturers of paint cans are eyeing the South & East Asia region to pursue rightsizing of their supply chains to accommodate high growth countries in the region.

China is expected to generate the maximum incremental $ opportunity for the paint cans market by the end of the forecast period. Strong economic growth of India is the key driver for the local paint industry. India’s paint consumption has been registering double-digit figures for the past few years, making it highly attractive in terms of growth rate of the paint cans market.

The continuous expansion of the building & construction industry in countries such as Indonesia, Thailand, South Korea, and Japan, is likely to represent an enormous growth opportunity for the paint cans market during the forecast period. Overall, South & East Asia regions are projected to witness a notable growth rate of the paint cans market throughout the forecast period.

Buy this report @ https://www.futuremarketinsights.com/checkout/6677

Competition Landscape: Global Paint Cans Market

The FMI report includes a detailed competition landscape, which includes profiles and assessment of paint can manufacturers operating in the global paint cans market. Key manufacturers of paint cans profiled include – Ardagh Group, S.A., Ball Corporation, RPC Group Plc., Silgan Containers LLC, Kian Joo Can Factory Berhad, Colep Portugal, S.A., BWAY Corporation (MAUSER Packaging Solutions), National Can Industries Pty. Ltd., Allied Cans Limited, Aaron Packaging, Inc., Allstate Can Corporation, Lancaster Containers, Inc., Baltic Packaging A/S, Envases Universales Group, P. Wilkinson Containers Ltd., Sarten Ambalaj Sanayi Ve Ticaret A.S., and KW Plastic Inc.

About Us

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com

Website: https://www.futuremarketinsights.com

LinkedIn| Twitter| BlogsC

Wooden Cutlery Market – Future Scenario, Key Insights, Top Companies 2029

The wooden cutlery market is estimated to value at US$ 184.4 million in 2022 and is projected to reach US$ 245 million by 2028, at a CAGR of 4.8% during the forecast period.In the report, FMI suggests that the wooden cutlery are the better alternative to plastic and steel cutlery, owing to its eco-friendly and biodegradable properties. The global market for wooden cutlery has been segmented on the basis of product, end use, sales channel, and regions such as North America, Latin America, Europe, South Asia, East Asia, MEA, and Oceania.

Download the sample copy  @ https://www.futuremarketinsights.com/reports/sample/rep-gb-7605

As the global sustainability drive continues to reach new heights, a number of end users, especially foodservice industry, are leaning towards green solutions and biodegradable products, resulting in surge in the demand of wooden cutlery. Tapping into opportunities in new sectors and regions where restrictions have imposed on the use of single-use plastics will remain key to gaining competitive advantage for the market players, according to the FMI’s analysis.

North America Remains at the Forefront

FMI’s study analyses that North America is expected to remain at the forefront of the global wooden cutlery market throughout the forecast period. In North America, the wooden cutlery market is expected to be driven by increase in number of single-person households along with increase in living standards and changing lifestyles. Rapid adoption of online food services in the region has further escalated the demand for wooden cutlery. Simultaneously, increase in demand for biodegradable cutlery and growing awareness towards the ill effects of plastic will continue to contribute to the growth of the wooden cutlery market.

Opportunities Abound in East Asia & South Asia

East Asia holds significant share in the global wooden cutlery market, and is expected to attain notable CAGR during the forecast period. In East Asia, China is foreseen to remain prominent market, accounting for half of the revenue share during the forecast period. China, with low labour cost and highly efficient workers, produces large volume of wooden cutlery. Wooden cutlery made in China are available at comparatively low price, and are exported in large volume to other regions.

In South Asia, India is expected to remain prominent market for wooden cutlery. Online food delivery system is growing at tremendous pace in the region, with evolving organized foodservice retail chains.  Escalating demand for convenience among consumers has resulted in increased delivery of food and cutlery consumption. The trend of using biodegradable and eco-friendly cutlery is increasing in the region, due to awareness program carried out by wooden cutlery market players such as Pappco Greenware against the effects of single-use plastic cutlery. Such trends are thus expected to fuel the growth of the wooden cutlery market in South Asia.

Buy this report @ https://www.futuremarketinsights.com/checkout/7605

Wooden Cutlery Market: Vendor Insights

In this report, Future Market Insights has presented several strategies adopted by the key players in the wooden cutlery market, tracked by an analysis of the current developments. The key players, which have been profiled in the report on the wooden cutlery market includes Huhtamaki Group Oyj, Chefast kitchen accessories, Mede Cutlery Company, Eco-gecko Products Inc., Caoxian Luyi Wooden Product Co., Ltd., Bambu LLC, VerTerra Dinnerware, Leafware LLC, Biopac UK Ltd., Vegware Ltd., Bio Futura B.V., Ecoware Biodegradables Inc., Ecoriti, Vrag Fils Airlaid Pvt. Ltd, Natural Tableware, Packnwood (First Pack), Biotrem, Pavrex Wooden Products, Greenwood (Dalian) Industrial Co., Ltd., and Pappco Greenware, among others.

About Us

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com

Website: https://www.futuremarketinsights.com

LinkedIn| Twitter| Blogs

Cancer Tissue Diagnostics Market Key Players : Thermo Fisher Scientific Inc., Abcam plc., BioGenex, Abbott Laboratories, F.Hoffmann-La Roche Ltd.

[250 Pages Report] The global cancer tissue diagnostics industry is hugely driven by sheer number of biomarkers used for early cancer detection from blood or plasma, while prevalence of lung, breast and prostate cancers has been another constant driving factor to the demand growth. Despite getting battered by the outbreak of the COVID-19, the industry players are coming back to track with the increase in investment in research & development (R&D) activities and focus on launching wider variety of products.

The latest revised edition on ‘cancer tissue diagnostics’ market study by Future Market Insights (FMI) provides a holistic overview of the global industry along with thorough analysis of the demand-supply patterns, and growth & restraining factors during the forecast period of 2021 to 2031. According to the report, the cancer tissue diagnostics industry will expand at close to 8.5% CAGR, while North America, Western Europe, Asia Pacific, and Latin America will remain hotspots for stakeholders in this industry. As per the report, North America will have the highest market share, more than 40%, through 2031.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-4191

Key Takeaways from Study

  • Rapid traction of immunohistochemistry (IHC) test to propel the demand growth
  • The United States to maintain its lead in the world’s biggest cancer tissue diagnostics industry North America
  • Germany to remain the major contributor to Western Europe cancer tissue diagnostics industry
  • China and India remain lucrative in the APEJ (Asia Pacific Excluding Japan) cancer tissue diagnostics industry
  • The United States, Japan, France, Italy, South Korea, and a few other countries to exhibit significant growth through 2031

“Growing inclination towards biomarker tests is anticipated to bolster the demand for cancer tissue diagnostic solutions substantially. As per the data revealed by the Organization for Economic Co-Operation and Development (OECD), the global biomarkers industry for companion diagnostics was worth US$ 8.4 Billion in 2016. As this value is forecast to rise further, the cancer tissue diagnostic solution providers are subject to higher revenue in the coming years,” says an FMI analyst.

How Rise in Cases of Cancer is Spearheading the Growth of Cancer Tissue Diagnostic Equipment Manufacturers?

According to the report on cancer published by the World Health Organization (WHO) on 3rd March, 2021, approximately 70% of deaths from cancer occur in low and middle-income countries, while cancer is the second leading cause of death globally and is responsible for approximately 10 million deaths per year. While this indicates the fatality and risks associated with cancer, it also signifies the importance of early diagnosis of cancer, which is resulting in growing adoption of timely diagnosis for various cancers such as lungs, breast, colon, and liver, to name a few.

The recent report by WHO states that late-stage presentation and lack of access to diagnosis and treatment are what make it more fatal for patients, while comprehensive treatment is reportedly available in more than 90% of high-income countries. Such reports are spreading awareness among people, which in turn is favoring the suppliers of cancer tissue diagnostics equipment.

Who is Winning in this Space?With the competition getting stricter, key players in the global cancer tissue diagnostics industry are embracing strategic ways to launch more effective products to target broader application areas. For instance,

  • Abbott Laboratories launched its new products such as Vysis ALK Break Apart FISH Probe Kit, and others in the last 5 years
  • Bio Rad Laboratories Inc. launched its new Liquicheck™ Tumor Marker Control equipped with 3 levels and 17 cancer antigens and popular tumor markers a couple of years back

More Valuable InsightsIn its latest report, FMI offers an unbiased analysis of the cancer tissue diagnostics market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of test type (immunohistochemical (IHC) test (breast cancer, stomach (gastric) cancer, colorectal cancer, prostate cancer, and others) and in situ hybridization (ISH) test (breast cancer, non-small cell lung cancer (NSCLC), bladder cancer, and others)) across seven major regions of the world (North America, Latin America, Europe, East Asia, South Asia, Oceania, and MEA).

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-4191

Cancer Tissue Diagnostics Market – Segmentation by CategoryTest Type

  • Immunohistochemical (IHC) Test
    • Breast Cancer
    • Stomach (Gastric) Cancer
    • Colorectal Cancer
    • Prostate Cancer
    • Others
  • In Situ Hybridization (ISH) Test
    • Breast cancer
    • Non-Small Cell Lung Cancer (NSCLC)
    • Bladder Cancer
    • Others

Region

  • North America
  • Latin America
  • Europe
  • Middle East and Africa (MEA)
  • East Asia
  • South Asia
  • Oceania

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports : https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Gamma Knife Market is projected to reach US$ 507.0 million by 2031

[200 Pages Report] FMI, in its research report, has covered the Gamma Knife market in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America Gamma Knife market, valued at US$ 46.3 Mn in 2014 will expand at a CAGR of 7.5% through 2025, reaching a valuation of over US$ 100 Mn by 2025.

Future Market Insights (FMI) provides vital insights on the key regions in the global Gamma Knife market in its latest report, “Gamma Knife Market: Global Industry Analysis and Opportunity Assessment 2015-2025”. According to the report, Asia Pacific Excluding Japan (APEJ) will emerge as the most lucrative region for the global Gamma Knife market by the end of 2025.

Rise in geriatric population and preference for less time-consuming treatment are the key factors fuelling the Gamma Knife market in North America. Increase in the prevalence of cancer, coupled with shift towards painless and non-invasive surgeries are other key drivers of the market.

Rise in per capita healthcare expenditure is also fuelling the Gamma Knife market in North America. For example, 17.7% of America’s GDP was spent on healthcare in 2011. Increase in funding for R&D on non-invasive treatment is also providing an impetus to the Gamma Knife market in North America.

According to Cancer.org, in the US, nearly 1,658,370 new cancer cases are expected to be diagnosed in 2015. Owing to these new diagnoses, the demand for non-invasive treatment options is expected to witness a surge.

In terms of compound annual growth rate (CAGR) and market value, FMI expects Asia Pacific Excluding Japan (APEJ) to emerge as the most lucrative market by the end of forecast period.

Currently valued at US$ 43.9 Mn, the Asia Pacific Excluding Japan (APEJ) Gamma Knife market is projected to expand at over 10% CAGR through 2025, reaching a valuation of US$ 131.5 Mn. APEJ is expected to account for nearly 30% of the market value share of the global Gamma Knife market by 2025.

The same factors that are driving the North America Gamma Knife market are fuelling the market in APEJ as well. However, the funding for research and development is expected to be comparatively lower than that in North America.

The leading companies operating in the Gamma Knife market are Elekta, Varian Medical Systems, and Huiheng Medical.

Gamma Knife tools account for nearly 40% of total revenues of Elekta. The company has a strong presence in North America and Europe. The company has strategic partnerships with prominent institutes, such as Swedish Cancer Institute and Ottawa Hospital.

FMI’s research on the Gamma Knife market revealed that approximately 950 employees at Elekta are involved in research and development activities. The company aims to exploit market opportunities and focus on radiotherapy market. The company’s capacity to drive the business further from the existing installed base becomes critical as it is subject to stringent market expectations.

North America is the most lucrative market for Varian Medical System, with the region accounting for nearly 46% of the total revenues. The company has a strong presence globally in terms of brand recognition and technology.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-589

A key opportunity for Varian Medical System is to expand in invasive surgery equipment by leveraging established brands. However, lack in safety measures for patients and staff from high radiations.

The company is focusing on R&D activities for high-quality and software which require trained professional for usage and safety. These activities involve increasing interconnectivity of products for a seamless operation.

Gamma Knife Market – Key Segment By Disease Indication:

  • Brain Metastasis
  • Cancer
  • Arteriovenous Malformation (AVM)
  • Trigeminal Neuralgia
  • Others

By Anatomy:

  • Head
  • Neck
  • Other Body Parts

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-589

By Geography:

  • North America
  • Europe
  • APAC
  • Latin America
  • Middle East and Africa

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports : https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Continuous Renal Replacement Therapy Market is likely to grow at a CAGR of 7.7% through 2027

[198 Pages Report] Acute kidney injury (AKI) is a common type of kidney disorder with high morbidity and mortality worldwide. Patients from low-resource regions are more prone to acute kidney injuries. The incidence of acute kidney injuries varies greatly in Asia due to significant variation in climate, geographical attributes, ethnic groups and socioeconomic status. The global continuous renal replacement therapy market was valued at US$ 1 Billion in terms of value in 2021, according to a latest research by Future Market Insights (FMI). The report on continuous renal replacement therapy further projects significant growth potential with average year-on-year growth rate of 7.7% through 2027.

Continuous renal replacement therapy is conducted for blood purification in patients suffering from acute kidney injury who unable to withstand rapid fluid and electrolyte exchange of conventional hemodialysis. Continuous renal replacement therapy involves the removal of blood from the arterial lumen catheter through the peristaltic movement and pushing it through a hemofilter before getting pumped into a patient via a venous lumen of catheter. Rising incidence of acute kidney injuries, multiple organ failure and other renal injuries had increased the demand for dialysis sessions.

Numerous advantages of continuous renal replacement therapy over the conventional dialysis procedure is a primary factor driving the adoption of continuous renal replacement therapy. Conventional dialysis systems are operated manually and all associated tasks are solely controlled by the user or caregiver. However, technological advancements in currently available continuous renal replacement systems allows the automatic management of disease parameters. Hence, most of the problems are being directly handled by automated digital machines, which is not possible in case of conventional systems, thus reducing the labour cost.

To expand their commercial footprint across the globe, several manufacturers of continuous renal replacement therapy are focusing on introducing new technologies and upgrading their existing products along with simultaneous focus on strategic alliances for the sale and promotion of their products. For instance, in 2015, Fresenius Medical Care AG & Co. KGaA launched multi Filtrate PRO, a therapy system for continuous renal replacement therapy for the treatment of acute kidney failure in critically ill patients at intensive care units. Innovations in extracorporeal technologies will play a critical role in the long-term sustainability of continuous renal replacement therapy devices. The advent of continuous renal replacement therapy devices will eventually attract a new patient base. For instance, in September 2017, Baxter International Inc. launched 3-In-1 oXiris Set for sepsis management protocols & continuous renal replacement therapy, which was previously indicated only for continuous renal replacement therapy. The commercialisation of such multimodal devices is expected to enhance the ROI for hospitals. The introduction of novel autonomous CRRT devices will marginally reduce physician intervention and the cost of treatments in intensive care units. The intuitive platform with touch screen and step-by-step automated instructions promotes ease of use during procedures.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-1211

Companies are investing in future growth by expanding their healthcare services businesses through acquisitions as well as the purchase of expertise and relevant technologies in the area of research and development. In 2016, Fresenius Medical Care spent US$1.3 Bn on capital expenditures, acquisitions and the purchase of intangible assets minus income from divestments. The majority of capital expenditures were used for equipping existing & new clinics, preserving & expanding production capacity, primarily in North America, Germany, Asia Pacific and France, as well as for dialysis machines made available to customers and for care coordination.

FMI segmented the global continuous renal replacement therapy market into product type, end user & regions. In terms of revenue, the consumables segment is expected to hold a substantial market share over the forecast period. The segment is expected to exhibit a significant CAGR of 8.5% over the forecast period.

FMI’s report covers some of the key companies operating in the continuous renal replacement therapy market, which include Fresenius Medical Care AG & Co. KGaA; Baxter International Inc.; B. Braun Melsungen AG; Medica SpA, Nikkiso Co., Ltd.; Nipro corp.; Toray Medical Co., Ltd.; NxStage Medical, Inc.; Asahi Kasei Corp. and Medtronic plc.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-1211

Segmentation

The report offers a comprehensive taxonomy of the continuous renal replacement therapy market based on product type, end user and region. Continuous renal replacement therapy is sold in two types: systems and consumables. The consumables segment covers various types of hemofilter sets, solutions and other accessories.

Increased healthcare spending across emerging economies is expected to encourage the establishment of new multi-specialties in dialysis centres and hospitals, which is, in turn, expected to promote the demand for CRRT. The continuous renal replacement therapy market has been analysed across various regions, which include North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan, Japan and MEA.

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports : https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Single Dose Radiotherapy Services Market to grow at 6.1% CAGR over the forecast period 2030 | FMI

[244 Pages Report] In single-dose radiotherapy, a single dose of radiation is delivered directly to the tumor in a few minutes and is said to be a safe and effective method for treating men having low-risk prostate cancer. According to Future Market Insights (FMI), the demand for single-dose therapy is expected to rise considerably, enabling the market to surpass US$ 1.1 Bn by 2021. In the coming years the rising cases of breast cancer will support the expansion of the market.

Single-dose radiotherapy substitutes the requirement for extra hospital visits, with benefits for patient safety and well-being. Single-dose radiotherapy is delivered during or soon after surgery for breast cancer and is considered a viable alternative to conventional external beam radiotherapy.

Increasing technological advancements in radiotherapy procedure for the treatment of breast cancer and prostate cancer have led to the surging adoption of single-dose radiotherapies in clinical practice associated with improved outcomes. Single-dose radiotherapy is recognized as an extremely cost-effective treatment compared with other cancer treatments.

Increasing investments in the market, increasing number of research and development projects, and favorable regulatory policies are some factors enabling growth in the single dose radiotherapy services market. For example various government organizations such as American Cancer Society is investing in research and development programs for development of single dose radiotherapy. Recently the American cancer society have funded almost 162 research programs with around $67 million to encourage breast cancer research activities.

The COVID-19 pandemic has changed the national healthcare significances and expenditure however this is considered to be a short-term impact on the single-dose radiotherapy services market. The single-dose radiotherapy services market is expected to experience short-term negative growth owing to a sharp reduction in the number of single-dose radiotherapy services adoption rate in developed and emerging countries.

As a result of the continuing spread of COVID-19, various service providers are focusing on a novel approach to the treat pneumonia associated with COVID-19 using a single low dose of external beam radiation therapy which is known as Single Dose Radiation Therapy (SDRT). Previously various studies are reported regarding use of single small fraction of radiation to treat viral and bacterial pneumonia. Thus, scientists are believing that one small dose of radiotherapy can be effective for covid-19 treatment. This is providing an opportunity for single dose radiotherapy market to grow.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-13033

Key Takeaways from Single-Dose Radiotherapy Services Market Study

  • Despite restricted growth amid COVID-19, the demand for single dose radiotherapy is expected to rise at nearly 5% in 2021
  • As a result of increasing incidence of breast cancer, the U.S. will account for over 90% sales in North America
  • Increasing focus on early diagnosis will enable the U.K. register 2.4% Y-o-Y growth in 2021
  • Germany and France are expected to exhibit increasing demand to tackle concerns pertaining to rising incidence of cancer
  • Increasing focus on research and development will drive growth in Japan and South Korea

 “Rising prevalence along with increasing awareness regarding breast and prostate cancer and the importance of early diagnosis, besides favorable reimbursement will offer lucrative growth opportunities for service providers in the long term,” says the FMI Analyst

Increase in Funding For Research Activities Offers Growth OpportunitiesLeading service providers in the single dose radiotherapy services market are strengthening their market position through collaboration with various government organization. Governments in various developed and developing countries are actively taking initiatives to encourage various research activities for the development of single-dose radiotherapy. For instance, In Brazil, government is taking initiative to create awareness regarding cancer treatment and research programs.

Pink October campaigns are arranged in Brazil by government, whose aim is to share facts about breast cancer, promoting awareness, providing countless access to diagnostic and therapeutic services, and funding to reduced mortality. One more example is the Blue November campaign, which works analogously to Pink October, however emphasize on prostate cancer.

Who is Winning?The global market is set to expand in the forecast period, due to the rising prevalence of breast cancer and prostate cancer globally and the adoption of single-dose radiotherapy. Leading organizations within the market are set to focus on research and development to offer early and precise diagnosis of the ailment, besides offering effective patient care.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-13033

Want more insights?Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2030. The global single-dose radiotherapy services market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on the single-dose radiotherapy services market on basis of the main indication in detail, cover every aspect of the market such as (breast cancer and prostate cancer), therapy (External Beam Radiotherapy and Internal Beam Radiotherapy), and service provider (Hospitals, Radiotherapy Centers and Specialized cancer institute) across seven major regions.

Single Dose Radiotherapy Services Market by CategoryIndication

  • Breast Cancer
  • Prostate Cancer

Therapy

  • External Beam Radiotherapy
  • Internal Beam Radiotherapy

Service Provider

  • Hospitals
  • Radiotherapy Centers
  • Specialized Cancer Institutes

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/13033

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • The Middle East and Africa (MEA)
  • Oceania

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports : https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Ocular Drug Delivery System Market sales will total US$ 27.82 Billon by 2031

[250 Pages Report] According to Future Market Insights (FMI), the demand for ocular drug delivery system is expected to rise considerably, enabling the market to surpass US$ 14,471.2 Mn in valuation by the end of 2021. The market is forecast to exhibit 6.8% CAGR between 2021 and 2031.

Ocular drug delivery systems are designed for dispensing drug, biologic, biopharmaceutical, and botanical therapeutics for treating macular degeneration, glaucoma, presbyopia, allergy, anti-viral, dry eye, anti-infective and anti-inflammatory indications.

To overcome the ocular drug delivery barriers and improve ocular bioavailability, various conventional and novel drug delivery systems have been developed such as  ointments, emulsion, suspensions, aqueous gels, Nano micelles, liposomes, , and in situ thermosensitive gels for the earlier mention ocular diseases.

Glaucoma is the second-leading cause of blindness worldwide, accounting for up to 8% of total blindness. In India, glaucoma is the leading cause of irreversible blindness with at least 12 million people affected and nearly 1.2 million people blind from the disease. More than 90 percent of glaucoma cases remain undiagnosed in the community.

Thus the high incidence of ophthalmic diseases, resulting in the rise significant patient population, is driving the global ocular drug delivery systems market.

Ocular drug has to pass the water-fat-water membranous structure of cornea and this changing environment presents a significant barrier. That is why, for almost four decades, researchers have been involved in developing intraocular sustained-release drug delivery platforms.

Owing to the rigorous research studies, approvals for new ocular drug delivery techniques are currently recorded globally. This has helped the market to gain momentum over the last few years.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-6027

Key Takeaways from Ocular Drug Delivery System Market Study

  • Increasing focus on pharmaceutical innovation and research on drug delivery technologies is driving a transition towards particulate drug delivery systems, which will account for over 68% of the market in 2021.
  • Ophthalmic solution for ocular drug delivery system is expected to account for 60% the global market share by 2031.
  • Among distribution channels, hospital pharmacies accounted for 40% of the market share in 2031. Soaring influx of patients for treatment and availability of intensive care support have propelled the demand in the sehment.
  • North America holds the maximum share, owing to the presence of Tier1 players, high per-capita healthcare expenditure, and favorable reimbursement policies in the region.
  • The U.S. holds a more than 44% share in the global ocular drug delivery systems market.
  • The U.K. and Germany are leading markets in Europe, accounting for more than 41% of the Europe market in 2021.
  • South Korea is the fastest growing market in East Asia, exhibiting 10.3% CAGR through 2031.

“Increasing prevalence of eye infections, innovation in drug delivery technologies, and rising clinical trials are creating lucrative growth opportunities for ocular drug delivery system sales,” says the Future Market Insight analyst.

Increase in Funding for Research Activities Offers Growth OpportunitiesLeading manufacturers in the ocular drug delivery system market are strengthening their market position through collaboration with various other organizations. Governments in developed and developing countries are actively taking initiatives to encourage research pharmaceutical products.

For instance, In April, 2017, Santen Pharmaceuticals announced a strategic investment in Regenerative Patch Technologies LLC, a U.S. based company engaged in development of ophthalmic therapies.

Pharmaceutical giants are expected to benefit from the globalization of labor forces, that is, employment of skilled local labor at cheaper rates to derive larger cost savings. Furthermore, this will create room for research and development (R&D) investments.

As per data from EFPIA and PhRMA, annual pharmaceutical (R&D) expenditures increased at 2.5% p.a. in Europe as compared to 3.3% p.a. in the U.S. over the latest measurable period 2016-2020. This will also create opportunities for the expansion of the market.

Who is Winning?The global market is set to expand due to the rising prevalence of eye infections. Leading players within this space are expected to focus on research and development to offer an early and precise diagnosis of ailment, besides offering effective patient care.

Some of the leading players in the ocular drug delivery system market include but are not limited to Allergan Plc., Graybug Vision Inc., Ocular Therapeutix, Inc., Alimera Sciences, pSivida, Santen Pharmaceutical Co., Ltd, Taiwan Liposome Company Ltd., Envisia Therapeutics, Eyegate Pharma, Valeant Pharmaceuticals International, Inc, Vision Ophthalmology Group GmbH, Clearside Biomedical, URSAPHARM Arzneimittel GmbH.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-6027

Want More Insights?Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global ocular drug delivery systems market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on the ocular drug delivery systems treatment on basis of the key indication in detail, cover every aspect of the market such as technology, dosage form, distribution channel across seven major regions.

About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Ocular Drug Delivery Systems Market by Category

Technology

  • Implantable Ocular Drug Delivery Systems
  • Particulate Drug Delivery Systems
  • Nano-Particle Drug Delivery System

Dosage Form

  • Ophthalmic Solution
  • Ophthalmic Suspension
  • Ophthalmic Emulsion
  • Ophthalmic Gels
  • Ophthalmic Ointments

Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Store
  • Mail Order Pharmacies

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-6027

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports : https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

U.S. Animal Model Market is projected to increase at a high CAGR of 4.1 % (2022-2032)

As per Future Market Insights’ latest industry analysis, the U.S. animal model market was valued at over US$ 921.9 Mn in 2021 and is anticipated to exhibit a CAGR of close to 4.1% over the forecast period (2022-2032).

Animal models are predominantly used to gather information regarding the disease and its prevention, diagnosis, and treatment. They are being used to resolve a wide range of scientific concerns, ranging from basic science to the discovery and evaluation of new vaccines and therapies. Animals are used because of the similarities in biology across most mammals.

Get Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14527

Personalized medicine is also known as precision medicine which utilizes data about a specific patient or an individual’s genes to plan treatment for a disease. Animal models can play important role in the development of new approaches for personalized medicine. Increasing adoption of personalized medicine will drive sales of animal model in the forthcoming years.

Toxicity testing in animals is done to discover potential side effects from an agent’s exposure and to generate dose-response relationships. Animal testing is important for the early detection of the potential risk to humans or as models to study the causes, pathogenesis, progression, and treatment of diseases.

Organizations and legislations such as the Federal Food, Drug, and Cosmetic Act (FFDCA), Environmental Protection Agency (EPA), Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), and Organization for Economic Co-operation and Development (OECD) determine the testing guidelines for toxicity testing on animals.

Some factors such as the high production volume of chemicals testing in the U.S., increasing generation and utilization of novel GM animal strains in toxicity studies, and the development and attempted validation of several animal tests to screen chemicals for endocrine (hormone)-disrupting activity are expected to drive the growth in the market.

For in-depth insights, Download a PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14527

Key Takeaways:

  • Based on species, the mice model segment is expected to hold nearly 62.6% of the total market share 2022, with sales growing at a 5.1% CAGR.
  • In terms of therapeutics, the oncology accounted for more than 32.0% of the total market share in 2021, and the trend is expected to continue over the forecast period.
  • By application, sales in the drug discovery/development segment commanded 65.4% of the total market share in 2021.
  • Based on end user, the academic & research institutes segment accounted 36.6% of the total market share in 2021.

Key Players:

  • Charles River Laboratories
  • The Jackson Laboratory
  • Taconic Biosciences, Inc.
  • Genoway
  • Envigo (Inotiv, Inc.)
  • Marshall BioResources
  • Janvier Labs
  • Applied stem cells
  • Biocytogen
  • Transposagen Biopharmaceuticals, Inc. (Hera Bio Labs)
  • Cyagen
  • Ingenious targeting labs
  • Crown Bioscience Inc. (JSR Corporation).
  • Harbour Biomed
  • Sinclair Bio Resources
  • Alpha Genesis Inc.
  • Creative Animodel
  • DaVinci Biomedical Research Products, Inc

For in-depth competitive analysis, Buy Now @ https://www.futuremarketinsights.com/checkout/14527

Market Competition

Key players operating in the U.S. animal model market are expanding their business through partnerships and acquisitions with other companies to improve their global footprint. Following are a few examples of acquisitions:

  • In October 2021, The Jackson Laboratory completed the acquisition of Charles River Laboratories Japan’s Research Models & Services (RMS), which allows advancement in the company’s scientific improvements in basic research and drug discovery.
  • In November 2021, Inotiv, Inc., which is a leading contract research organization (CRO) completed its acquisition of Envigo RMS Holding Corp. to expand its R&D sector.
  • In February 2021, Biocytogen completed the acquisition of a third Beacon Optofluidic system. This acquisition expanded Biocytogen’s service platform in the Boston area.

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the animal model market in its latest study, presenting a historical demand assessment of 2017–2021 and projections for 2022– 2032.

The research study is based on the species – (rats, mice, pigs, rabbits, monkeys, dogs, cats, other species), therapeutics- (metabolic diseases, cardiovascular diseases, neurological diseases, and oncology), application (drug discovery/development and basic & applied research) end-user (academic & research institutes, pharmaceutical companies, biotechnology companies, and CROs) and across seven key regions of the world.

Future Market Insights’ Expertise in Life Sciences and Transformational Health

Our expert team of industry analysts comprising management graduates, medical professionals, engineers, and project managers provides insights on emerging therapy areas, diagnostic tools, medical devices and components, reimbursement and market access, biotechnology, and life science research products and services to equip decision-makers with sound inputs and strategic recommendations.
About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports : https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Dental Sealants Market is set to increase at a 4.7% CAGR in terms of volume, reaching US$ 680.0 Mn in 2022

Dental Sealants Market Analysis and Segment Forecasts To 2022, provides an in-depth analysis of the global dental sealants market with segmentation based on  Product, End User & Region.

NEWARK, Del., April 29, 2022 /PRNewswire/ — As per Future Market Insights’ latest revised industry analysis, the global dental sealants market is projected to reach a valuation of US$ 680 Million in 2022, likely to surge at a vigorous 4.7% CAGR between 2022 – 2032.

Demand in the market is slated to surge on the back of rising awareness and necessity for oral hygiene and dental care. In addition to this, high prevalence of lifestyle-associated dental disorders is underpinning the need for technologically advanced dental equipment, which is expected to boost the market

Dental sealants are thin plastic coatings that are applied to the chewing (occlusal) surfaces of permanent teeth (molars and premolars) to prevent decay. Molar and premolar teeth have grooves or “fissures” on their chewing surfaces decay with time. These cracks can be deep, difficult to clean, and even smaller than a single toothbrush bristle. Dental sealants give added protection to grooved and pitted areas by covering the fissured area with a smooth surface.

Request a Sample to Obtain Authentic Analysis and Comprehensive Market Insights@ https://www.futuremarketinsights.com/reports/sample/rep-gb-14552

Rising disposable income in developing economies is fueling the preference for aesthetical and cosmetic dentistry. With the trend of beauty and wellness building interest among the general population, advancements in dental adhesives and sealants are gaining traction to secure patient or customer satisfaction.

Moreover, high prevalence of common oral diseases such as dental caries of permanent teeth is propelling sales in the market. With unhealthy lifestyles and dietary habits, the prevalence is expected to increase in the forthcoming years. High sugar intake, caffeine and smoking are the major causes of tooth decay and caries.

Rising government initiatives and investments in providing oral healthcare and awareness are anticipated to fuel sales in the market. The presence of favorable healthcare reimbursement policies in various countries will augment the growth in the market over the forecast period.

“Increasing preference for dental cosmetic procedures, along with technological advancements in materials used in dental procedures will create opportunities for growth in the forthcoming years,” says an FMI analyst.

Leading Companies Profiled in Dental Sealants Market are:

  • 3M
  • Dentsply Sirona
  • PULPDENT Corporation
  • SHOFU Dental GmbH
  • Den-Mat Holdings, LLC
  • Centrix, Inc
  • GC America Inc.
  • Henkel AG & Co. KGaA
  • Dux Industries, Inc.
  • Johnson Services, Inc.
  • Procter & Gamble
  • GlaxoSmithKline plc.

Key Takeaways:

  • By product, the glass ionomer segment is forecast to account for 56.6% of the total market share by 2032, with sales growing at a 3.9% CAGR.
  • In terms of end user, sales in the hospitals held 44.4% of the total market share in 2021, and the trend is expected to continue over the forecast period.
  • Germany will emerge as a lucrative pocket in the Europe dental sealants market, with demand growing at a 4.5% CAGR through 2032.
  • China is expected to account for a lion’s share of the East Asia dental sealants market, with sales projected to increase at a 8.7% CAGR.
  • The U.S. will dominate the North America dental sealants market. Total sales in the North America market will account for 30.4% of the total market share.

Feel Free to Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-14552

Competition Landscape

Key players operating in the dental sealants market are investing in product portfolio expansion to gain a competitive edge in the market. Leading players are also investing in acquisitions and partnerships to expand their global footprint. For instance:

  • In December 2021, Nobel Biocare announced the U.S. FDA clearance of the company’s N1™ implant system. This implant system signifies a noteworthy step in advancing toward patient-centric implant solutions.
  • In February 2022, GSK announced its independent consumer healthcare company to be called Haleon.

Key Market Segments Covered In Dental Sealants Industry Research

By Product:

  • Glass Ionomer
  • Polyacid Modified Resin

By End-User:

  • Hospitals
  • Dental Clinics
  • Ambulatory Surgical Centers

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 8-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Over-The-Counter (OTC) Veterinary Drugs Market projected to expand at a CAGR of 8.1% 2022-2032

Global Over-The-Counter (OTC) Veterinary Drugs market is expected to grow at a decent rate owing it to the increase in number of manufacturers for Over-The-Counter (OTC) veterinary drugs, worldwide. There are variety of drugs available in the market as Over-The-Counter (OTC) veterinary drugs for the safe use in animals. These drugs are available in various forms, topical drugs are available as gels, oils, creams, and sprays for various applications. Antibiotics and non-steroidal anti-inflammatory drugs are very common Over-The-Counter (OTC) veterinary drugs in the market. The drugs are available for various medical conditions related with the skin, eyes, and allergic reactions to the animals.

The Over-The-Counter (OTC) veterinary drugs market is well equipped with the retail pharmacies by the end user segment. Injectable drug involve vaccines, which are majorly used by the companion animals for their safety and improving their well-being. The Over-The-Counter (OTC) veterinary drugs market is expected to propel during the forecast period with the growing awareness on the safety and prevention of diseases among companion animals.

Over-The-Counter (OTC) Veterinary Drugs, also termed as non-prescription drugs are drugs that are available without any prescription. These drugs are effective and safe when all the directions on the label or directed by the healthcare professional are followed. The FDA in the U.S. considers when a specific drug is effective and safe enough to be sold over-the-counter. Over-the-counter (OTC) veterinary drugs usage is attributable to the savings on cost incurred on clinical visit and on the drug cost. There are limited veterinary drugs that are approved and available to veterinarians.

Request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-9190

The veterinarians often depend on the use of different sources and types of drugs to treat their patients. Over-The-Counter (OTC) veterinary drugs are checked on the assurance of the product effectiveness, safety, and manufacturing to stringent standards for purity, quality, and potency. The FDA Centre for Veterinary Medicine (CVM) is responsible for the manufacturing and distribution of veterinary food additives and drugs. Over-The-Counter (OTC) veterinary drugs are regulated under The Federal Food, Cosmetic, and Drug ACT, which regulated statutory provisions that govern all the key regulations of Over-The-Counter (OTC) veterinary drugs. The Act formulate drugs as, “articles for use in the cure, diagnosis, treatment, mitigation, or prevention of diseases in animals or man”.

Over-The-Counter (OTC) Veterinary Drugs Market: Drivers and Restraints-

Over-The-Counter (OTC) Veterinary Drugs are poised to witness a significant growth owing it to the paradigm shift from Rx to OTC by major pharmaceutical manufacturers. Increasing tendency of people towards the health of their companion animals in developed regions, majorly, and immense cost savings with Over-The-Counter (OTC) veterinary drugs pose various advantages, further boosting demand for Over-The-Counter (OTC) veterinary drugs.

However, several serious issues with OTC drugs pertaining to inappropriate substance abuse vehemently and diagnosis of the animal might obstruct market growth for Over-The-Counter (OTC) veterinary drugs during the forecast timeframe. This has also resulted in withdrawal of various Over-The-Counter (OTC) veterinary drugs used for therapy from the market over the years. Stringent regulations regarding Over-The-Counter (OTC) veterinary drugs and substance abuse related issues might also hinder market growth for Over-The-Counter (OTC) veterinary drugs during the forecast period.

Over-The-Counter (OTC) Veterinary Drugs Market: Region-wise Outlook

Over-The-Counter (OTC) veterinary drugs market is immensely concentrated in major developed economies like the U.S., Japan, and China. The United States is expected to witness a moderate growth due to market saturation in a few product categories. Technological advancements is however, expected to boost market growth for Over-The-Counter (OTC) veterinary drugs worldwide.

Increase in consumer appetite for Over-The-Counter (OTC) veterinary drugs for their companion animals, and growing need of curbing the veterinary-related healthcare costs is expected to fuel the market growth for Over-The-Counter (OTC) veterinary drugs in the Europe region. Increase in efforts for Over-The-Counter (OTC) veterinary drugs licensing for treatment of various diseases in animals is also expected to boost the market growth for Over-The-Counter (OTC) veterinary drugs during the forecast period. However, traditional medications for veterinary disease treatment might slow down the market growth for Over-The-Counter (OTC) veterinary drugs in the Asia-Pacific and MEA region.

Over-The-Counter (OTC) Veterinary Drugs Market: Key Market Participants

Some of the market participants in the Global Over-The-Counter (OTC) Veterinary Drugs market identified across the value chain include: Merck & Co., Inc., Zoetis, Inc., Eli Lilly and Company, Virbac, Bayer AG, Sanofi, Vetoquinol S.A., Boehringer Ingelheim International GmbH, and Dechra Pharmaceuticals PLC.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-9190

The report covers exhaust analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (India, ASEAN, Australia & New Zealand)
  • China
  • Japan
  • Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Over-The-Counter (OTC) Veterinary Drugs Market: Segmentation

On the basis of Drug Class, Over-The-Counter (OTC) Veterinary Drugs Market can be segmented as:

  • H2 Receptor Antagonists
  • Non-steroidal Anti-inflammatory Drug
  • Artificial Tears and Ocular Lubricants
  • Antihistamine
  • Antibacterial
  • Glucocorticosteroid
  • Antidiarrheal Agents
  • Nutraceuticals
  • Others

On the basis of Form, Over-The-Counter (OTC) Veterinary Drugs Market can be segmented as:

  • Topical
  • Oral
  • Injectable

On the basis of Distribution Channel, Over-The-Counter (OTC) Veterinary Drugs Market can be segmented as:

  • Retail Pharmacies
  • Mail-order Pharmacies
  • Hypermarkets & Supermarkets

On the basis of geography, Over-The-Counter (OTC) Veterinary Drugs Market can be segmented as:

  • North- America
  • Eastern Europe
  • Western Europe
  • Asia-Pacific excluding China & Japan
  • China
  • Japan
  • Middle East and Africa
  • Latin America

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-9190

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current, and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 8-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs